These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

449 related articles for article (PubMed ID: 17017330)

  • 1. A case report of neuroleptic malignant syndrome without fever in a patient given aripiprazole.
    Rodriguez OP; Dowell MS
    J Okla State Med Assoc; 2006; 99(7):435-8. PubMed ID: 17017330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Atypical neuroleptic malignant syndrome in patients treated with aripiprazole and clozapine: a case-series study and short review.
    Tseng PT; Chang YC; Chang CH; Wang HY; Cheng YS; Wu CK; Chen YW; Chung W
    Int J Psychiatry Med; 2015; 49(1):35-43. PubMed ID: 25838319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ziprasidone- and lithium-induced neuroleptic malignant syndrome.
    Borovicka MC; Bond LC; Gaughan KM
    Ann Pharmacother; 2006 Jan; 40(1):139-42. PubMed ID: 16352776
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome versus serotonin syndrome: the search for a diagnostic tool.
    Sokoro AA; Zivot J; Ariano RE
    Ann Pharmacother; 2011 Sep; 45(9):e50. PubMed ID: 21878660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant syndrome secondary to aripiprazole initiation in a clozapine-intolerant patient.
    Patel MK; Brunetti L
    Am J Health Syst Pharm; 2010 Aug; 67(15):1254-9. PubMed ID: 20651315
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Atypical neuroleptic malignant syndrome: diagnostic controversies and considerations.
    Picard LS; Lindsay S; Strawn JR; Kaneria RM; Patel NC; Keck PE
    Pharmacotherapy; 2008 Apr; 28(4):530-5. PubMed ID: 18363536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aripiprazole and neuroleptic malignant syndrome.
    Chakraborty N; Johnston T
    Int Clin Psychopharmacol; 2004 Nov; 19(6):351-3. PubMed ID: 15486522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome with aripiprazole and lithium: a case report.
    Ali S; Pearlman RL; Upadhyay A; Patel P
    J Clin Psychopharmacol; 2006 Aug; 26(4):434-6. PubMed ID: 16855467
    [No Abstract]   [Full Text] [Related]  

  • 14. [Catatonia and neuroleptic malignant syndrome: two disorders on a same spectrum? Three case reports].
    Luchini F; Lattanzi L; Bartolommei N; Cosentino L; Casamassima F; Litta A; Mauri M; Cassano GB
    Riv Psichiatr; 2012; 47(2):178-85. PubMed ID: 22622253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aripiprazole and neuroleptic malignant syndrome.
    Brunelle J; Guigueno S; Gouin P; Tamion F; Thibaut F
    J Clin Psychopharmacol; 2007 Apr; 27(2):212-4. PubMed ID: 17414250
    [No Abstract]   [Full Text] [Related]  

  • 16. A hazardous side effect of neuroleptics: diagnosis and treatment.
    Epperly TD; McGlaughlin VG; Leo KU
    Geriatrics; 1990 Aug; 45(8):58-62. PubMed ID: 1974232
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroleptic malignant syndrome from aripiprazole in an agitated pediatric patient.
    Palakurthi HB; Parvin MM; Kaplan S
    Clin Neuropharmacol; 2007; 30(1):47-51. PubMed ID: 17272970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reconsidering Rigidity in the Diagnosis of Neuroleptic Malignant Syndrome: A Case Report.
    El Khoury R; Kassab A; Dagher R; Javelot H; El Chammay R; Richa S
    J Psychiatr Pract; 2020 Jul; 26(4):320-323. PubMed ID: 32692129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.